TechNavio recognizes the following companies as the key players in the Regenerative Medicine Market in the US: Baxter International Inc., Medtronic Inc., Stryker Corp., and Zimmer Holdings Inc.
Commenting on the report, an analyst from TechNavio’s team said: “There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market.”
According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D.
Further, the report states that the stringent regulatory approval process for Regenerative products is one of the major challenges faced by the market. The stringent approval processes inhibits the entry of new products into the market.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Advanced Cell Technology Inc., Athersys Inc., Cytori Therapeutics Inc., CryoLife Inc., Genzyme Corp., Integra Life Sciences Holdings Corp., Kensey Nash Corp., NeoStemInc., Osiris Therapeutics Inc., RTI Biologics Inc., and many more.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/regenerative-medicine-market-us-2012-2016
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report -Regenerative Medicine Market in the US 2012-2016
